深圳市崇光生物医药科技有限公司成立，注册资本2500万人民币

Core Viewpoint - Shenzhen Chongguang Biomedical Technology Co., Ltd. has been established with a registered capital of 25 million RMB, focusing on various biomedical services and research [1] Company Overview - The legal representative of Shenzhen Chongguang Biomedical Technology Co., Ltd. is Zhao Ming [1] - The company is jointly owned by Shenzhen Quanzhong Biomedical Technology Co., Ltd. (80% stake) and Shandong Quanzhong Biomedical Technology Co., Ltd. (20% stake) [1] - The company is classified under the scientific research and technical service industry, specifically in engineering and technical research and development [1] Business Scope - The general business scope includes technology services, development, consulting, exchanges, transfers, and promotion, as well as engineering and technical research and development [1] - The company is also involved in medical research and development, bio-based materials technology research, and bio-chemical product technology research [1] - The licensed business activities include drug clinical trial services, drug wholesale, and drug retail, which require approval from relevant authorities [1] Company Details - The registered address is located at 160 Chuangtou Road, Unit 503, Guangming Technology Financial Building, Dongkeng Community, Guangming District, Shenzhen [1] - The company is a limited liability company with an operational period until February 3, 2026, with no fixed term thereafter [1]